Inhibition of the different complement pathways has varying impacts on the serum bactericidal activity and opsonophagocytosis against Haemophilus influenzae type b

Autor: Muri, L., Schubart, A., Thorburn, C., Zamurovic, N., Holbro, T., Kammüller, M., Pluschke, G., Ispasanie, E.

Publikováno v: Frontiers in Immunology. 13

Defense againstHaemophilus influenzaetype b (Hib) is dependent on antibodies and complement, which mediate both serum bactericidal activity (SBA) and opsonophagocytosis. Here we evaluated the influence of capsule-specific antibodies and complement in

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a88a0322021470bb5a757a1705d7b65c
https://doi.org/10.3389/fimmu.2022.1020580

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Characterization of vaccine antigens of meningococcal serogroup W isolates from Ghana and Burkina Faso from 2003 to 2009.

Autor: Ispasanie E; Novartis Vaccines Institute for Global Health, 53100, Siena, Italy ; MRC Centre for Immune Regulation, School of Immunity and Infection, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK ; Molecular Immunology Department, Swiss Tropical and Public Health Institute, Basel, 4002, Switzerland., Pluschke G; Molecular Immunology Department, Swiss Tropical and Public Health Institute, Basel, 4002, Switzerland ; University of Basel, Basel, 4003, Switzerland., Hodgson A; Navrongo Health Research Centre, Navrongo, PO Box 114, Ghana., Sie A; Centre de Recherche en Santé de Nouna, PO Box 02, Nouna, Burkina Faso., MacLennan C; Novartis Vaccines Institute for Global Health, 53100, Siena, Italy ; MRC Centre for Immune Regulation, School of Immunity and Infection, College of Medicine and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK., Koeberling O; Novartis Vaccines Institute for Global Health, 53100, Siena, Italy.

Publikováno v: F1000Research [F1000Res] 2014 Nov 03; Vol. 3, pp. 264. Date of Electronic Publication: 2014 Nov 03 (Print Publication: 2014).